Willow Creek Wealth Management’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Willow Creek Wealth Management’s Portfolio NYMX Stock Details NYMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-18,724	Closed	-$8K	–	138
2022 Q3	$8K	Hold	18,724	–	–	﹤0.01%	118
2022 Q2	$8K	Hold	18,724	–	–	﹤0.01%	123
2022 Q1	$24K	Hold	18,724	–	–	﹤0.01%	118
2021 Q4	$24K	Sell	18,724 -5,500	-23%	-$8.78K	0.01%	122
2021 Q3	$50K	Hold	24,224	–	–	0.01%	114
2021 Q2	$38K	Hold	24,224	–	–	0.01%	112
2021 Q1	$54K	Hold	24,224	–	–	0.02%	94
2020 Q4	$60K	Hold	24,224	–	–	0.02%	89
2020 Q3	$60K	Hold	24,224	–	–	0.02%	85
2020 Q2	$86K	Hold	24,224	–	–	0.04%	78
2020 Q1	$57K	Hold	24,224	–	–	0.03%	65
2019 Q4	$53K	Sell	24,224 -9,900	-29%	-$19.5K	0.02%	82
2019 Q3	$62K	Hold	34,124	–	–	0.03%	85
2019 Q2	$49K	Hold	34,124	–	–	0.02%	82
2019 Q1	$67K	Buy	34,124 +16,562	+94%	+$35.1K	0.03%	72
2018 Q4	$23K	Hold	17,562	–	–	0.01%	66
2018 Q3	$43K	Hold	17,562	–	–	0.02%	72
2018 Q2	$59K	Hold	17,562	–	–	0.03%	69
2018 Q1	$74K	Buy	+17,562	New	+$60.9K	0.04%	68

Other funds holding NYMX

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

CAN

Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

FCFC

First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return

Willow Creek Wealth Management's NYMX Position: Q4 2022 in Review

Willow Creek Wealth Management sold out of Nymox Pharmaceutical Corp (NYMX) in Q4 2022, closing a stake of 18,724 shares — an estimated $8K sold.

Willow Creek Wealth Management first reported a position in NYMX in Q1 2018 and held it in 19 quarters. The position peaked at $86K in Q2 2020. 37 funds tracked by Wall St. Rank hold NYMX as of Q4 2022.

Willow Creek Wealth Management reported no remaining Nymox Pharmaceutical Corp position as of Q4 2022 after selling out during the quarter.
Willow Creek Wealth Management sold 18,724 Nymox Pharmaceutical Corp shares in Q4 2022, an estimated $8K.
Willow Creek Wealth Management first reported a position in Nymox Pharmaceutical Corp in Q1 2018 and held it in 19 quarters.
Willow Creek Wealth Management's Nymox Pharmaceutical Corp position peaked at $86K in Q2 2020.
37 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q4 2022.

Based on Willow Creek Wealth Management's 13F filing for Q4 2022, filed 1 Mar 2023.